Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jay B Shah

Showing results (31-40 of 71) with videos related to

Pageof 8
Sort By:
Urologic Oncology|December 11, 2020
Bupivacaine local anesthetic to decrease opioid requirements after radical cystectomy: Does formulation matter?Bogdana Schmidt, Hriday P Bhambhvani, Daniel R Greenberg, et al.
Urology|September 2, 2014
Intravesical tumor involvement of the trigone is associated with nodal metastasis in patients undergoing radical cystectomyRobert S Svatek, Timothy N Clinton, Clark A Wilson, et al.
The Journal of Urology|November 3, 2015
Final Pathological Stage after Neoadjuvant Chemotherapy and Radical Cystectomy for Bladder Cancer-Does pT0 Predict Better Survival than pTa/Tis/T1?Homayoun Zargar, Kamran Zargar-Shoshtari, Yair Lotan, et al.
European Urology|May 9, 2012
Neoadjuvant chemotherapy in small cell urothelial cancer improves pathologic downstaging and long-term outcomes: results from a retrospective study at the MD Anderson Cancer CenterSiobhan P Lynch, Yu Shen, Ashish Kamat, et al.
The Journal of Urology|July 25, 2015
A Multi-Institutional Analysis of Outcomes of Patients with Clinically Node Positive Urothelial Bladder Cancer Treated with Induction Chemotherapy and Radical CystectomyKamran Zargar-Shoshtari, Homayoun Zargar, Yair Lotan, et al.
The Journal of Urology|January 14, 2018
Neoadjuvant Dose Dense MVAC versus Gemcitabine and Cisplatin in Patients with cT3-4aN0M0 Bladder Cancer Treated with Radical CystectomyHomayoun Zargar, Jay B Shah, Bas W van Rhijn, et al.
Molecular Cancer Therapeutics|December 28, 2012
Current preclinical models for the advancement of translational bladder cancer researchDavid J DeGraff, Victoria L Robinson, Jay B Shah, et al.
Annals of Surgical Oncology|July 9, 2016
Phase 1b Trial to Evaluate Tissue Response to a Second Dose of Intravesical Recombinant Adenoviral Interferon α2b Formulated in Syn3 for Failures of Bacillus Calmette-Guerin (BCG) Therapy in Nonmuscle Invasive Bladder CancerNeema Navai, William F Benedict, Guangcheng Zhang, et al.
European Urology Focus|July 30, 2017
Absence of Tumor on Repeat Transurethral Resection of Bladder Tumor Does Not Predict Final Pathologic T0 Stage in Bladder Cancer Treated with Radical CystectomyJanet Baack Kukreja, Sima Porten, Vishnukamal Golla, et al.
BJU International|August 26, 2016
Risk of hospitalisation after primary treatment for prostate cancerStephen B Williams, Zhigang Duan, Karim Chamie, et al.
Pageof 8

Showing results (31-40 of 71) with videos related to

Sort By:
Pageof 8
Urologic Oncology|December 11, 2020
Bupivacaine local anesthetic to decrease opioid requirements after radical cystectomy: Does formulation matter?Bogdana Schmidt, Hriday P Bhambhvani, Daniel R Greenberg, et al.
Urology|September 2, 2014
Intravesical tumor involvement of the trigone is associated with nodal metastasis in patients undergoing radical cystectomyRobert S Svatek, Timothy N Clinton, Clark A Wilson, et al.
The Journal of Urology|November 3, 2015
Final Pathological Stage after Neoadjuvant Chemotherapy and Radical Cystectomy for Bladder Cancer-Does pT0 Predict Better Survival than pTa/Tis/T1?Homayoun Zargar, Kamran Zargar-Shoshtari, Yair Lotan, et al.
European Urology|May 9, 2012
Neoadjuvant chemotherapy in small cell urothelial cancer improves pathologic downstaging and long-term outcomes: results from a retrospective study at the MD Anderson Cancer CenterSiobhan P Lynch, Yu Shen, Ashish Kamat, et al.
The Journal of Urology|July 25, 2015
A Multi-Institutional Analysis of Outcomes of Patients with Clinically Node Positive Urothelial Bladder Cancer Treated with Induction Chemotherapy and Radical CystectomyKamran Zargar-Shoshtari, Homayoun Zargar, Yair Lotan, et al.
The Journal of Urology|January 14, 2018
Neoadjuvant Dose Dense MVAC versus Gemcitabine and Cisplatin in Patients with cT3-4aN0M0 Bladder Cancer Treated with Radical CystectomyHomayoun Zargar, Jay B Shah, Bas W van Rhijn, et al.
Molecular Cancer Therapeutics|December 28, 2012
Current preclinical models for the advancement of translational bladder cancer researchDavid J DeGraff, Victoria L Robinson, Jay B Shah, et al.
Annals of Surgical Oncology|July 9, 2016
Phase 1b Trial to Evaluate Tissue Response to a Second Dose of Intravesical Recombinant Adenoviral Interferon α2b Formulated in Syn3 for Failures of Bacillus Calmette-Guerin (BCG) Therapy in Nonmuscle Invasive Bladder CancerNeema Navai, William F Benedict, Guangcheng Zhang, et al.
European Urology Focus|July 30, 2017
Absence of Tumor on Repeat Transurethral Resection of Bladder Tumor Does Not Predict Final Pathologic T0 Stage in Bladder Cancer Treated with Radical CystectomyJanet Baack Kukreja, Sima Porten, Vishnukamal Golla, et al.
BJU International|August 26, 2016
Risk of hospitalisation after primary treatment for prostate cancerStephen B Williams, Zhigang Duan, Karim Chamie, et al.
Pageof 8